 Connection
John Carroll to Fibrinolytic Agents
This is a "connection" page, showing publications John Carroll has written about Fibrinolytic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.069 |
|
|
|
-
Lakkireddy D, Windecker S, Thaler D, S?ndergaard L, Carroll J, Gold MR, Guo H, Brunner KJ, Hermiller JB, Diener HC, Schmidt B, MacDonald L, Mansour M, Maini B, Levine J. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial). Am Heart J. 2019 05; 211:45-53.
Score: 0.035
-
Tirschwell DL, Turner M, Thaler D, Choulerton J, Marks D, Carroll J, MacDonald L, Smalling RW, Koullick M, Gu NY, Saver JL. Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention. J Med Econ. 2018 Jul; 21(7):656-665.
Score: 0.034
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|